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As commonly understood, clonal hypotheses for immunoglobulin (Ig) diversity require
that antigens selectively stimulate different antibody cell clones and that the daughter
cells of each clone produce antibodies having identical antigen-combining sites (1-3) . In
support of this view is the fact that in mice neoplastic Ig-producing cell lines (plasmacyto-
mas) usually retain their individuality and homogeneity of Ig phenotype after repeated
transplantation in vivo (4) ; also, the Ig's of many plasmacytomas have been shown to be
specific for various antigens common to the environment of the mouse (5) . In these
respects, plasmacytomas seem to share the same properties as inferred for single clones of
experimentally induced antibody-forming cells (6-8) . However, the stability of Ig pheno-
type in mouse plasmacytomas is not without exception . These exceptions mostly take the
form of defective Ig-producing cell lines that secrete only light (L)' chains or that do not
secrete an Ig at all (nonproducers) (9-11) .
In contrast to defective Ig-producing cells, we have obtained two plasma-
cytoma cell lines in culture (104-76 and 352-57) that produce intact Ig's contain-
ing heavy (H) and L chains that differ from those produced by the "parent"
plasmacytomas (MOPC 104E andMOPC 352) . In this respect and as a matter of
convenience, we refer to 104-76 and352-57 as variant Ig-producing cell lines . The
central question raised by these results is whether these cell lines represent
clonal variants of MOPC 104E and MOPC 352 or secondary tumors of host
origin . As clonal variants, it would be of interest to know whether this apparent
variable Ig expression has meaning for antibody diversity . As secondary host
tumors, one would like to know the mechanism oftumor induction .
Materials and Methods
Allotypes ofDifferentBALBlc Congenic Mice .'
￿
BALB/c mice congenic for different Ig allotypes
were used exclusively in these studies . In Table 1, the H-chain allotypes of these congenic strains
* This work was supported by U.S . Public Health Service grants CA-04946, CA-06927 and RR-
05539 from the National Institutes of Health, andby an appropriation from the Commonwealth of
Pennsylvania .
f Present address : Laboratory of Cellular and Comparative Physiology, Gerontology Research
Center, Baltimore City Hospitals, Baltimore, Maryland 21224 .
'Abbreviations used in this paper : BME-199, 80% Eagle's basal medium and 20% medium 199
supplemented with 20%heat-inactivated FCS, 3mM glutamine, sodium bicarbonate, andantibiot-
ics ; H, heavy ; L, light; MOPC, mineral oil-induced plasmacytomas .
'The CB and CAL congenic mouse strains originated in thelaboratory ofDr . Michael Potter,as
did all of the mouse plasmacytomas used in this study .
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TABLE I
Allotypes of Different BALBlc Congenic Mouse Strains
Allotype determinants of the H-chain link-
age group*
*12,13,14 F19 G1 .9 .7 .8 H9,11
*13.17 F19 4G8.7 .8 H4
*15 Fs 2G- H9.16
" BALB/c mice congenic for different Ig allotypes are designated CAL
for those having the allotype of the AL/N mouse strain and CB for
those having the allotype of the C57BL/Ka mouse strain (5) . The
number after the hyphen refers to how many backcross generations
preceded the derivation of each congenic strain .
f A, F, G, andH refer to the Ig classes IgA, IgG,, IgG2a, andIgG2b (4) .
These Ig classes have been denoted Ig-2, Ig-4, Ig-1, and Ig-3 elsewhere
(12) . The assigned allotypic determinants are numbered according to
Potter and Lieberman (4) .
are listed . A, F, G, andHrefer respectively to the Ig classes IgA, IgG,, IgG2a and IgG2b which are
distinguished allotypically according to the assigned numbers of Potter andLieberman (4, 5) . 3The
abbreviated designation of BALB/c congenic mice that carry the Ig genes of the C57BL allotype
(CB mice) or the Ig genes of the AL/N allotype (CAL mice) is according to the notation used by
Potter (5) .
Ig Preparations from Plasmacytoma-Bearing Mice .' Transplantable lines of mineral oil-in-
ducedplasmacytomas(MOPC) ofBALB/c or of CB mice were stored in liquid nitrogen freezers . For
routine propagation, plasmacytomas were transplanted subcutaneously . Depending on the allo-
type of the mouse in which the tumor arose, each plasmacytoma used in this study (unless
otherwise stated) wasgrown in congenic BALB/c mice having a different allotype than that ofthe
tumor Ig .
(NH4)2S04 precipitation and DEAE-cellulose chromatography (at 0.02M P04, pH 7.4) were the
methods (13) used to obtain 7S Ig from the pooled sera of plasmacytoma-bearing mice . Papain
digestion of 7S Ig (14) yielded Fe and Fab fragments that were separated over DEAE-cellulose
columns by means of a linear salt gradient (0.005MP0 4 to 0.3M PO,, pH 8.0) (15) .
Salt-precipitated IgMofMOPC 104E anda variant ofMOPC 104E (104-76) in 0.1MP04 , pH 7.4
were fractionated over a 1 .5 x 90-cm column of Bio-Gel A-1.5m Agarose (Bio-Rad Laboratories,
Richmond, Calif.) Iodination ofIgMwasdone according to thechloramineTmethod ofHunter and
Greenwood (16) ; the free 1'51 was separated from the labeled protein by passage over amixed bed of
ion-exchange Resin (Amberlite IR 413 & Bio-Rad AG 1 x 8) layered on top of a G-50 Sephadex
column .
Antisera . Goat antiserum specific for mouse IgM was purchased from Maloy (Springfield,
Va .) . This antiserumwasabsorbed with the lambda-containing IgG28 from the HOPC-1 plasmacy-
toma in order to remove residual anti-lambda (a) specificity . For this as well as other absorptions,
Ig antigens were coupled to Sepharose beads according to the method of Axen et al . (17) . Rabbit
antiserum directed againstmouse L chains of either the A or kappa (]c) classes wasgiven to us by
Dr . Martin Weigert of this institute .
Antiallotype antibodies were produced in C57BL/6and AL/N mouse strains after the injection of
agglutinates of rabbit red cell ghosts and 7S Ig of C3H/HeJ mice (18) . Antisera were tested by
precipitation in micro-Ouchterlony .
C57BL/6antiserum obtained during the first 6mo oftheimmunization regimenwas specific for
G',',' and F'9 allotypic determinants, but in later months (9-12 mo), most of the surviving mice
switched entirely to the production of anti-F 19 antibodies . Monospecificity of C57BL/6 antisera to
3 These Ig classes have been denoted by Herzenberg et al . (12) as Ig-2, Ig-4, Ig-1, and Ig-3,
respectively . Here, individual allotypic determinants are designated by asecond number (e.g ., Ig-
1.1) .1000
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either G"a or F'" was assured after absorption with Sepharose-conjugated Ig of the appropriate
plasmacytomas as well as with Sepharose-conjugated Fab fragments derived from the 7S Ig
fraction of C3H/HeJ mice immune to rabbit ghosts .
TheAL/N antisera gave precipitin bands to BALB/c and C57BL7S Ig . When this antiserum was
tested against Ig preparations from different plasmacytomas, it gave precipitin bands of identity to
IgG2, and IgG2o, but it failed to precipitate IgG, . For the purpose ofthis test, the tumors producing
IgG2 ., (MOPC 173, LPC-1), lgG2b (MOPC 195, MOPC 352) andIgG, (MOPC 31,.) were all grown in
BALB/c congenic mice (CAl-20) that have the same Ig allotype as AL/N mice . On the basis of these
results, we have tentatively designated the AL/N antiallotype serum as anti-GIH" .
In contrast to the specificity of mouse antiallotype sera for Ig determinants on the Fc fragment,
we raised a BALB/c antiserum againstdeterminants foundon the Fab fragments ofMOPC 352 Ig .
This BALB/c antiserumwas absorbed to monospecificity with Sepharose-conjugated Fc fragments
ofMOPC 352 Ig, afterwhich it failed to precipitate normal Ig of BALB/c, AL/N or C57BL mouse
strains ; nor did this antiserum precipitate any of the Ig preparations from the many plasmacyto-
mas tested . Hence, we refer to this antisera as anti-352 Fab or anti-352 idiotype .
Tissue Culture Medium .
￿
Cells were adapted to culture in a medium composed of 80% Eagle's
basal medium and 20% medium 199 supplemented with 20%n heat-inactivated fetal calf serum
(FCS), 3mM glutamine, sodium bicarbonate, and antibiotics (BME-199) . After complete adapta-
tion to in vitro growth, tumor cells were usually cultured in Eagle's minimal essential medium
supplemented with 10% FCS, 3mM glutamine, sodium bicarbonate, and antibiotics (MEM) .
Adaptation of Plasmacytomas to Culture .
￿
Tumor cells were adapted to culture by an animal
passage technique (19, 20) ; this procedure of alternate growth in vitro and in vivo was continued
until tumor cells were able to proliferate to high density in culture . To facilitate the handling of
tumor cells, plasmacytomas were injected intraperitoneally into each new host mouse to induce
ascites . The ascites fluid (2-3 ml) which contained tumor cells, erythrocytes, peritoneal macro-
phages and other reticulum cells, was aseptically aspirated . Red cells were lysed after two
successive periods (1 min each) of hypotonic shock in distilled water . The washed cells were
resuspended in BME-199, placed in 75-cm' plastic flasks (Falcon Plastics, Div . of BioQuest,
Oxnard, Calif.) or in Spinner bottles (200 ml vol) andincubated at 37°C in an atmosphere of95% air
and 5% CO, . Cultures were observed daily and usually fed thrice weekly . Tumor cells were
considered fully adapted to culture after five successive in vitro passages and at such time were
frozen and stored in liquid nitrogen . Cell counts were made in a hemacytometer andthenumber of
viable cells scored on the basis of their ability to exclude eosin .
Results
Cell Growth of an IgG2,Producing Plasmacytoma During Adaptation to
Culture . To select for plasmacytoma cells that can grow in culture, it is
necessary to place tumor cells under alternating conditions of in vitro and in
vivo growth (20) . The results ofFig . 1 seem to reflect thiskind of cell selection for
MOPC 173 (173-39) after it was placed in spinner culture for the third time .
Here, in a culture medium maintained at 200 ml, the cell concentration and cell
viability (by eosin exclusion) were followed for over a 200-day period . After 17
days in culture, the number oftumor cells seeded (6.0 x 106 ) declined to less than
3 x 104 living cells, i.e ., only 0 .05% of the cells counted were viable . However,
over the next 20 days, the number of viable cells increased exponentially to
greater than 10' cells . After two dilutions of the culture with fresh medium, the
number of cells remained relatively static until day 55, at which time 173-39
began to show signs of being adapted . From day 65 onward, the cell growth was
exponential in the range of 104-106 cells/ml with a calculated doubling time of 19
h . When culture densities exceeded 106 cells/ml, we found that the cell growth
slowed considerably and that the fraction of viable cells dropped below 90% .
After 80 days in Spinner culture 173-39 was also placed in culture flasks where it
continues to produce IgG2a in its 20th serial passage .J
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Growth behavior ofMOPC 173 (173-39) during adaptation to culture in BME-199
containing 20% fetal calf serum . After 173-39 cells were placed in spinner culture for the
third time, the cell concentration and cell viability (cells that didnot stain with eosin) were
recorded for over 200 days . The 173-39 cell population was fed periodically and when cell
densities approached 10 8 cells/ml, the culture was "split" (decanted) and diluted with new
medium as indicated (---) . Throughout the entire period of adaptation, the culture volume
was maintained at 200 mi .
Extrapolating the initial growth curve of 173-39 (see Fig . 1) back to zero time
shows that less than 50 cells gave rise to the 173-39 cell line, i.e ., only about one
in 10'cells of the starting population could grow in culture . Such rare cells (10-')
must be different from most cells, i.e ., they must be variant cells . And the
inclusion ofan altered Ig phenotypeamong such cells could explain the variant1002
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Ig-producing cell lines that we observed in two of six different Ig-producing
plasmacytomas adapted to culture: PC-3 (IgG2,,), TEPC-15 (IgA), MOPC-173
(IgG2), PC-1171 (IgG, of an NZB mouse), MOPC-104E (IgM), and MOPC-352
(IgG2,) of C57BL allotype). The two variant cell lines are described next.
Detection of a MOPC 104E Variant in Culture.
￿
The first plasmacytoma
variant (104-76) was found in MOPC 104E, an IgM-producing tumor. IgM
molecules of MOPC 104E are distinguished by their X-light chains and by their
ability to bind al-3 Dextran (21) . Since we did not examine 104-76 for Ig markers
until after it was completely adapted to culture, we were surprised to find that
104-76 produced IgM molecules that were different than those of the MOPC 104E
line. As can be seen in Table 11, 104-76 produces IgM molecules containing K-
instead of A-light chains ; further, the IgM of 104-76 does not have antibody
specificity for al-3 Dextran. By testing frozen serum pools of MOPC 104E-
bearing mice of earlier transplant generations, we were able to determine that
the MOPC 104E tumor stopped synthesizing IgM molecules with Dextran-
binding specificity around the 64th transplant generation.
The basis for the data of Table 11 is as follows : both the IgM of 104-76 and
MOPC 104E (grown-up from frozen ampoules of transplant generation 50) were
twice-fractionated separately over a 1 .5 x 90-cm column of BioGel 1 .5A to give
nearly coincident peaks immediately after the void volume (this is illustrated in
Fig. 2) . When the protein in these peaks was concentrated and run against the
appropriate antisera, we observed the precipitin patterns shown in Fig. 3. Here,
the Ig's of different plasmacytomas (as arranged in the Ouchterlony wells) serve
to demonstrate the specificity of the antisera as well as that of the 104-76 Ig.
Other than what has already been summarized in Table 11, these results with
gel-fractionated IgM make it clear that the K- and X-chains of 104-76 are part of
the same molecule.
Comparative immunoelectrophoresis between the IgM of MOPC 104E and
104-76 revealed yet another difference (see Fig. 4), namely, that the IgM of 104-
TABLE 11
Detection of a MOPC 104E Variant (104-76) in Culture
* Animal passageand culture passagereferto thenumber of times 104-76 was
alternately grown in mice or serially passaged in culture.
$ The presence or absence of IgM heavy chains (A), of a- or K- light chains,
and ofantibody specificity for al-3 Dextran(Dex) is indicated with a plus (+)
or minus (-). NT denotes not tested.
MOPC 104E
transplant
generation
Generation
used for
culture
Animal
passage*
Culture
passage
Ig markersT
a K Dex
51-55
56-64 NT NT NT +
65-70 NT NT NT -
71-75 NT NT NT -
76 104-76 First NT NT NT -
104-76 Second NT NT NT -
104-76 Fifth + - + -
104-76 Tenth + - + -0D CPM
(280nm) (x10-5 )
0.5
0 .41-4
0 .3 - 3
50
￿
60
￿
70
￿
80
￿
90
￿
100 120
￿
160
ELUENT VOLUME (ML )
7S
FIG. 2 .
￿
Gel-filtration of IgM from MOPC 104E and 104-76 over a 1 .5 x 90 cm column of
BioGel A-1.5m agarose . The IgM in the pooled sera of tumor-bearing CB-17 mice was first
precipitated, concentrated and fractionated over the BioGel column (conditions : 1M NaCl
in 0.1 M PO,, pH 7.4) . 1-ml portion of each fractionated IgM preparation was recycled
separately over the same column to give the elution pattern seen : 0.2 Ing of ["'11104E,
specific activity, 5 x 10'cpm/Wg ; ("---"), 17 mg of 104-76 (O-O) ; and as a marker for the
column void volume, 0.2% Blue Dextran ("-") . A comparable coincidence of elution
profile was obtained with a mixture of ['91104E IgM and 104-76 IgM . The eluent volume of
IgGza from the LPC-1 plasmacytoma served as a 7S Ig marker (A-") .
FIG. 3 .
￿
Comparative analysis of the antigenic specificities of gel-fractionated IgM from
Fig . 2 . As indicated, theouter wells contained the following purified Ig preparations : 104-76
(2.0 mg/ml) ; 104E (1 .0 mg/ml except Ouchterlony C, 0.15 mg/ml) ; MOPC 46B (a-chains at 0.1
mg/ml) ; MOPC 173 (G' ,' - ' at 0.2 mg/ml) ; HOPC-1 (A-containing G'."' at 0.2 mg/ml) andFCS
(20% fetal calf serum) . The center wells had the following : (A) dextran (1 .0 mg/ml) ; (B) goat
anti-IgM ; (C) rabbit antimouse A-chain ; and (D) rabbit anti-K chain .
10031004
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76 does not migrate toward the anode as does theIgM ofMOPC 104E . The lack of
migration by 104-76 IgM cannot simply be attributed to the light chain substitu-
tion of rc for X since the rc-containing IgM ofTEPC-183 migrates as does the IgM
of MOPC 104E (Fig . 4 C) . This fact and the results of other experiments (to be
published separately) showing the IgM ofMOPC 104E and 104-76 to be dramati-
callydifferent in their susceptibility to papain digestion and different in theirA-
chain (H) antigenicity (as determined with a solid-phase radioimmune assay),
but having A-chains of indistinguishable size according to gel electrophoresis of
the separated p,-chainsin polyacrylamide containing 7% sodium dodecyl sulfate,
lead us to suspect that 104-76 may be expressing altered p.-chains or a p,-chain
class that is different than that of MOPC 104E .
Another point to be made from the results of Fig . 4 is the noted absence of the
104-76 variantin theMOPC 104E parent line . Although not shown here, neither
were we able to detect the variant IgMin tumor-bearing sera of later transplant
generations (71-75) . Thus, the loss of precipitin bands to Dextran after trans-
plant generation 64 was not accompanied by a detectable gain of 104-76 IgM.
Detection of a MOPC 352 Variant in Culture .
￿
A second plasmacytoma
variant (352-57) was found in MOPC 352 which originated in a BALB/c congenic
Fcc . 4 . Comparative immunoelectrophoresis of IgM-producing plasmacytomas (condi-
tions : 9 V/cm for 60 min in 1% agarose containing 0.05Mbarbital buffer,pH 8.6), Dextran (5
mg/ml) or goat anti-IgM sera were placed in the troughs as indicated . The wells contained
tumor-bearing serum (TBS) of mice in which either MOPC 104E, 104-76 or TEPC 183 was
growing . Also included were IgM preparations of MOPC 104E (8 .2 mg/ml) and 104-76 (17
mg/ml) that were obtained by fractionation over a 1.5 x 90 cm column of BioGel A-1.5m
agarose .S. J. HAUSMAN AND M. J. BOSMA
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mouse (CB-6) that was homozygous for a marker chromosome containing Ig
genes of the C57BL allotype. The IgG2h produced by MOPC 352 can be distin-
guished serologically from IgG, on the basis of its H" allotype . Further, MOPC
352 can be distinguished from all other plasmacytomas by means of a BALB/c
antiserum specific for antigenic determinants found on the Fab fragments of
MOPC 352 Ig (352 Fab marker).
The adaptation of MOPC 352 to culture, as it was alternately grown in vitro
and in vivo (in BALB/c mice) was followed by means of the 352 Fab marker. The
results of Table III indicate that the persistence of this marker faded during the
adaptation process such that the fully adapted 352-57 lost the 352 Fab marker
completely. We were inclined to accept 352-57 as a nonproducer but after
screening the tissue culture fluid against various antisera, we found that 352-57
was producing an Ig bearing the F" allotype.
Other than testing culture fluids for the 352 Fab marker, the basis for Table
III is as follows: 352-57 and MOPC 352 (from the same lot of frozen ampoules
from which 352-57 was originally started) were grown in BALB/c, CB-17 mice,
and CAL-20 mice ; two transplant generations later, we tested the sera of the
second tumor-bearing hosts for the presence of F'`', H1, and the 352 Fab marker .
The results are shown in Fig. 5. The absence ofF'" precipitin bands in the sera of
CB-17 mice bearing MOPC 352 (Ouchterlony A) held true even after concentrat-
ing the tumor Ig fivefold.
Discussion
We have presented evidence for the selection of variant plasmacytoma cells in
tissue culture. The action of selection was first indicated by the growth kinetics
of 173-39 during its adaptation to culture, the inference being that very few
tumor cells in the starting population (10-') can give rise to a cultured cell line,
and secondly by the detection of two variant Ig-producing cell lines (104-76 and
352-57) in cultures adapted from transplanted lines of MOPC 104E and MOPC
352 . What follows is a discussion of possible explanations for the presence or
occurrence of variant Ig-producing cells in a given plasmacytoma cell line.
TABLE III
Detection of a MOPC 352 Variant (352-57) in Culture
* Animal passage andculture passage refer to the number of times 352-
57 was alternately grown in mice or serially passaged in culture.
t Thepresence or absenceofdifferent Ig heavy-chain allotypes (F'", H")
and of the 352 Fab marker is indicated with a plus (+) or minus
NT denotes not tested.
MOPC 352
transplant
generation
Generation
used for
culture
Animal
passage
Culture
passage
Ig
F
markers$
H" 352 Fab
48 - + +
54 NT NT +
57 352-57 First NT NT +
352-57 Second NT NT
352-57 First + - -
352-57 Fifth + - -1006
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FIG. 5 .
￿
Comparative analysis of the antigenic specificities of Ig produced by MOPC-352
and 352-57 . As indicated, the outer wells contained tumor-bearingsera ofMOPC 195(H 9 ."),
MOPC 31c(F") and 352-57 grown in CB-17 (Ouchterlony A), in CAL-20 mice (Ouchterlony
B), and in BALB/c mice (Ouchterlony C) ; and purified preparations of 352 (0.2 mg/ml), 352
Fe (0 .1 mg/ml), and 352 Fab (0.2 mg/ml) . Themouse antiallotype sera placed in the center
wells was (A) C57BL/6 anti-F" ; (B) AL/N anti-GIHI; and (C) BALB/c anti-352 Fab.
The detection of variant Ig-producing plasmacytoma cells cannot be attrib-
uted to cross-contamination of 104-76 and 352-57 with other transplantable
plasmacytomas . MOPC 104E was the only IgM-producing tumor in our labora-
tory during the adaptation of 104-76 . Further, the BALB/c plasmacytoma
(MOPC 31) that we regularly carry and use as representative of the IgG,
allotype (F") produces an IgG, that has a strikingly different isoelectric-banding
pattern than the F'" globulin of 352-57 (our unpublished results) . Neither is
there any evidence for contamination of our frozen tumor bank since for retest-
ing purposes, we grew-up the MOPC 104E and MOPC 352 from the same lots of
frozen ampoules that were used in the 104-76 and 352-57 adaptation series
(Tables II and 111) .
Another possibility is that the parent tumor is biclonal so that 104-76 and 352-
57 may have been present in MOPC 104E and MOPC 352 from the time of
original tumor induction . Three arguments can be made against this view .
First, if the division rates of two incipient clones at the time of induction and
thereafter were to differ by only 5%, then the frequency oftumor cells from the
slower dividing clone would be of the order of 10-12 after 50 transplant genera-
tions . This assumes a conservative 15 cell divisions per transplant generation,
impartial host mice and equal selective value for the growth of each cell line
over 50 transplant generations . That these conditions would be fulfilled by
chance intwo of six Ig-producing plasmacytomas that we successfully adapted to
culture is improbable . Secondly, MOPC 352 was induced in a CB-6 mouse that
was bred to exclude the BALB/c allotype .' Therefore, we would not expect to
have a biclonal tumor ofmixed allotypes (352-57 produces IgG, of the BALB/c
allotype) . And thirdly, of the thousand or more BALB/c plasmacytomas that
' Potter, M . Personal communication .S . J . HAUSMAN AND M . J . BOSMA
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havebeen typed, only a rare few produce IgM.4 This makes it highly improbable
that 104-76 IgM is a biclonal contaminant ofMOPC 104E .
Two interesting explanations for the present observations remain, one being
that 104-76 and 352-57 represent secondary plasmacytomas induced in one of the
tumor-bearing hosts. In this case, we could suppose that the presence of the
original plasmacytoma was in some way responsible for the second . For exam-
ple, the particles (viruses) found in plasmacytoma cells (5) could be infectious
for nearby host cells or for attacking immune cells of the host, especially if the
reaction of cells immune to the tumor were to cause activation and release of
such viruses . The activation of murine leukemia viruses by graft-vs.-host reac-
tions in vitro when correlated with the high incidence of leukemia in graft-vs .-
host disease (22) supports the above possibility . Then, too, it seems significant in
this context that a high and rapid incidence of leukemia can be induced in
BALB/c mice with the Abelson virus (23) .
Another way in which host immune cells could become neoplastic is through
cell fusion with a plasmacytoma cell . In fact, cell fusion between two different
Ig-producing plasmacytoma cells ofBALB/c mice has been recently achieved in
vitro, although in this particular case the Ig phenotypes of both parent cells
continue to be produced by the hybrid cell line .' However, it is possible that
according to the principle of allelic exclusion, only one oftwo allotypes would be
produced in a hybrid cell for which the parent cells were each producing Ig
allotypes of different mouse strains before cell fusion .
Consistent with either of the above mechanisms for the induction of a host
tumor is the fact that 352-57 produces an F'4 allotype that characterizes the IgG,
ofBALB/c mice in which MOPC-352 was always grown.
A second explanation for 104-76 and 352-57 is that these cell lines represent
clonal variants of MOPC 104E and MOPC 352 . Evidence for variable Ig produc-
tion in some plasmacytomas is strong, beginning with the early work of Potter
and Kuff (9), who showed that different nodules of a primary tumor could secrete
the same L chain in combination with H-chains (HL2 on HL) or as free L chains .
With the adaptation of plasmacytomas to tissue culture, it was possible to
analyze closely defective Ig-producing variants . And primarily from the elegant
work of Scharff and co-workers (11, 24) and others (25), with cloned lines of
plasmacytomas, the following is known: (a) that the generation of defective Ig-
producing variants is spontaneous (11) ; and (b) that the frequency of variants is
high (10-a-10-4 per cell per generation) and peculiar to Ig production because
the frequency ofother variant cell traits such as resistance to drugs (puromycin,
6-thioguanine, 2-deoxyglucose, etc.) is less than 10-6 per cell pergeneration (24) .
On the basis of the preceding, any general instability of plasmacytoma cells is
not likely to be the cause of altered Ig production . Rather, the appearance of
defective Ig-producing cells is thought to reflect gene mutation or an unknown
epigenetic mechanism (24) that could either result in altered gene transcription
or altered assembly and secretion of Ig chains .
Unlike defective Ig-producing plasmacytomas, the two variants described in
this paper produce intact Ig's that containH or L chains that differ from those of
' Margulies, D., W. M. Kehuel, and M. Scharff. Personal communication .1008
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the "parent" lines . Results of a similar nature were recently reported by
Preud'Homme et al . (26) for clonal variants of MPC-11 that produced altered
IgG2,, H chains ; these included H chains having serological, chemical, and
assembly characteristics of IgG2dproducing plasmacytomas . However, the
MPC-11 variants were detected only after the cells were treated with the
mutagens,ICR 191 or Melphalan. Mutagens were not used in our studies and we
cannot easily attribute thevariant Ig serotypes produced by cell lines 104-76 and
352-57 to mutation of Ig structural genes . Rather, we seem to be dealing with
alterations in the regulation of Ig gene expression . Therefore, should gene
mutation pertain, it may involve regulatory genes that control the expression of
pre-existing Ig structural genes . For example, if different joining enzymes (or
episomes) were responsible for the putative translocation of different sets ofV
and C genes, any genetic alteration of the specific joining enzymes active in a
given plasmacytoma cell line could lead to an altered expression (or loss of
expression) of the tumor Ig .
Irrespective of mechanism, altered transcription of Ig genes could serve as an
explanation for the 352-57 variant . The parent cell line, MOPC 352, was derived
from a BALB/c congenic mouse (CB-6) that was homozygous for a marker
chromosome carrying the C57BL allotype genes.' However, we have strong
evidence to suggest the presence of BALB/c allotype genes in CB mice, the
products ofwhichare normally undetectable by conventional assays (18, and our
unpublished findings) . Therefore, one could suppose that a chance expression of
one of these hidden genes (F'4) in MOPC 352 occurred in a variant cell that had
selective value in culture .
The difficulty in ascribing physiological meaning to the possibility of variable
gene expression in the present work is twofold . First, plasmacytoma cells are
highly-aneuploid and it is possible that anomalous chromosomal alterations
could be responsible for the 104-76 and 352-57 variants . Secondly, we cannot be
sure that the variants 104-76 and 352-57 reflect spontaneous, noninduced events
as do for example the defective Ig-producing variants referred to earlier . Thus, it
remains to be seen if variants like 104-76 or 352-57 can be selected from cloned
lines of mouse plasmacytomas .
Summary
Murine plasmacytomas can be adapted to continuous in vitro culture by
alternate passage between culture and animal . We have found that the kinetics
of adaptation reflect a selection for the growth of variant plasmacytoma cells .
The inclusion of an altered immunoglobulin phenotype in such variant cells
could explain the Ig-producing variants that we observed in two of six trans-
plantable lines of plasmacytomas that were adapted to culture . The first var-
iant, an IgM-producing cell line (104-76), was adapted from a transplanted line
of MOPC 104E that had stopped producingIgM with binding specificity for al-3
Dextran. Unlike MOPC 104E, the IgM of 104-76 contains ic- instead of X-light
chains and probably contains an altered or different A-heavy chain . A second
variant (352-57) was found in an IgG2n-producing tumor (MOPC 352) which was
induced in a BALBic mouse strain (CB-6) that carried Ig genes of the C57BL/Ka
allotype . This cell line apparently switched from producing IgG2n molecules ofthe C57BL allotype (H9) and of a known idiotype to IgG, molecules of the
BALB/c allotype (F'9) without the idiotype marker . The propagation of a bi-
clonal plasmacytoma from the time of original tumor induction does not appear
as a likely explanation for these results . Rather, we seem to be dealing with
plasmacytoma variants or with the possible induction of secondary tumors of
host origin .
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